Trial intelligence / Profile preview

Antihypertensive efficacy of valsartan versus telmisartan in young adults with essential hypertension

IRCT20260701070040N1Phase 4Recruiting

Sponsor
Pak Emirates Military Hospital
Start
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of valsartan and telmisartan in essential hypertension (2 arms), sponsored by Pak Emirates Military Hospital. Started Aug 2026; status: recruiting.

02

Drugs

valsartantelmisartan
03

Conditions

essential hypertension

Beyond the preview

Go deeper on IRCT20260701070040N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20260701070040N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call